BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8049135)

  • 1. Molecular modeling of steroidal estrogens: novel conformations and their role in biological activity.
    Wiese TE; Brooks SC
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):61-73. PubMed ID: 8049135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular modeling analysis of diethylstilbestrol conformations and their similarity to estradiol-17 beta.
    Wiese TE; Dukes D; Brooks SC
    Steroids; 1995 Dec; 60(12):802-8. PubMed ID: 8650702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs.
    Kym PR; Anstead GM; Pinney KG; Wilson SR; Katzenellenbogen JA
    J Med Chem; 1993 Nov; 36(24):3910-22. PubMed ID: 8254621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
    Duax WL; Griffin JF; Weeks CM; Korach KS
    Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between estrogen structure and conformational changes in estrogen receptor/DNA complexes.
    Christman JK; Nehls S; Polin L; Brooks SC
    J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):201-10. PubMed ID: 7577701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal conformations and receptor binding of some 9,11-modified estradiols.
    Palomino E; Heeg MJ; Horwitz JP; Polin L; Brooks SC
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):75-84. PubMed ID: 8049136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.
    Anstead GM; Carlson KE; Katzenellenbogen JA
    Steroids; 1997 Mar; 62(3):268-303. PubMed ID: 9071738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.
    Wolohan P; Reichert DE
    Steroids; 2007 Mar; 72(3):247-60. PubMed ID: 17280694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL; Scali J
    Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of 4-fluoro estrogen analogues.
    Longcope C; Rafkind I; Arunachalam T; Caspi E
    J Steroid Biochem; 1983 Sep; 19(3):1325-8. PubMed ID: 6621038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs.
    Schwartz JA; Skafar DF
    Biochemistry; 1993 Sep; 32(38):10109-15. PubMed ID: 8399136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.
    Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL
    Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and study of B-nor-8-isoanalogs of steroid estrogens].
    Shavva AG; Selivanov SI; Starova GL; Boronoeva TR; Ishchenko IV; Gluzdikov IA; Sharetskiĭ AN; Isaeva VG; Surinov BP
    Bioorg Khim; 2002; 28(3):242-50. PubMed ID: 12077850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.
    Fink BE; Mortensen DS; Stauffer SR; Aron ZD; Katzenellenbogen JA
    Chem Biol; 1999 Apr; 6(4):205-19. PubMed ID: 10099132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of computational modeling approaches in studying the binding interactions of compounds with human estrogen receptors.
    Wang P; Dang L; Zhu BT
    Steroids; 2016 Jan; 105():26-41. PubMed ID: 26639429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE; Polin LA; Palomino E; Brooks SC
    J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.